These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20969716)

  • 1. Criteria for three-dimensional anorectal ultrasound assessment of response to chemoradiotherapy in rectal cancer patients.
    Murad-Regadas SM; Regadas FS; Rodrigues LV; Crispin FJ; Kenmoti VT; Fernandes GO; Buchen G; Monteiro FC
    Colorectal Dis; 2011 Dec; 13(12):1344-50. PubMed ID: 20969716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological analysis of distal margin for rectal cancer after preoperative chemoradiation therapy.
    Nishioka M; Shimada M; Kurita N; Iwata T; Morimoto S; Yoshikawa K; Higashijima J; Miyatani T
    Hepatogastroenterology; 2012 Oct; 59(119):2142-6. PubMed ID: 22366527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Preoperative Chemoradiotherapy on the Likelihood of Sphincter Preservation Surgery in Locally Advanced Distal Rectal Cancer: A Longitudinal Study Based on Pelvic Magnetic Resonance Imaging.
    Ihn MH; Kim YH; Kim DW; Oh HK; Lee SY; Park JT; Son IT; Park JH; Lee YJ; Kim JW; Lee KW; Kim JH; Shin E; Lee HS; Ahn S; Kang SB
    Ann Surg Oncol; 2015 Jul; 22(7):2159-67. PubMed ID: 25503346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.
    Lee SH; Lee KC; Choi JH; Oh JH; Baek JH; Park SH; Shin DB
    Jpn J Clin Oncol; 2008 Feb; 38(2):112-21. PubMed ID: 18263881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of three-dimensional anorectal ultrasonography in the assessment of rectal cancer after neoadjuvant radiochemotherapy: preliminary results.
    Murad-Regadas SM; Regadas FS; Rodrigues LV; Barreto RG; Monteiro FC; Landim BB; Holanda EC
    Surg Endosc; 2009 Jun; 23(6):1286-91. PubMed ID: 18813985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological response of locally advanced rectal cancer to preoperative chemotherapy without pelvic irradiation.
    Bensignor T; Brouquet A; Dariane C; Thirot-Bidault A; Lazure T; Julié C; Nordlinger B; Penna C; Benoist S
    Colorectal Dis; 2015 Jun; 17(6):491-8. PubMed ID: 25524450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Organ-Preserving Strategies on Anorectal Function in Patients with Distal Rectal Cancer Following Neoadjuvant Chemoradiation.
    Habr-Gama A; Lynn PB; Jorge JM; São Julião GP; Proscurshim I; Gama-Rodrigues J; Fernandez LM; Perez RO
    Dis Colon Rectum; 2016 Apr; 59(4):264-9. PubMed ID: 26953984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Watch and wait policy after preoperative radiotherapy for rectal cancer; management of residual lesions that appear clinically benign.
    Rupinski M; Szczepkowski M; Malinowska M; Mroz A; Pietrzak L; Wyrwicz L; Rutkowski A; Bujko K
    Eur J Surg Oncol; 2016 Feb; 42(2):288-96. PubMed ID: 26506863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management?
    Habr-Gama A; Sabbaga J; Gama-Rodrigues J; São Julião GP; Proscurshim I; Bailão Aguilar P; Nadalin W; Perez RO
    Dis Colon Rectum; 2013 Oct; 56(10):1109-17. PubMed ID: 24022527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of Pathological Complete Response Using Endoscopic Findings and Outcomes of Patients Who Underwent Watchful Waiting After Chemoradiotherapy for Rectal Cancer.
    Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Morikawa T; Fukayama M; Watanabe T
    Dis Colon Rectum; 2017 Apr; 60(4):368-375. PubMed ID: 28267003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
    Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
    Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial results of a randomized controlled trial comparing clinical and pathological downstaging of rectal cancer after preoperative short-course radiotherapy or long-term chemoradiotherapy, both with delayed surgery.
    Latkauskas T; Pauzas H; Gineikiene I; Janciauskiene R; Juozaityte E; Saladzinskas Z; Tamelis A; Pavalkis D
    Colorectal Dis; 2012 Mar; 14(3):294-8. PubMed ID: 21899712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative therapy for lower rectal cancer and modifications in distance from anal sphincter.
    Gavioli M; Losi L; Luppi G; Iacchetta F; Zironi S; Bertolini F; Falchi AM; Bertoni F; Natalini G
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):370-5. PubMed ID: 17524570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The adequacy of the distal resection margin after preoperative chemoradiotherapy for rectal cancer.
    Kim TG; Park W; Choi DH; Kim SH; Kim HC; Lee WY; Park JO; Park YS
    Colorectal Dis; 2014 Aug; 16(8):O257-63. PubMed ID: 24422744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy.
    Bujko K; Nowacki MP; Nasierowska-Guttmejer A; Michalski W; Bebenek M; Pudełko M; Kryj M; Oledzki J; Szmeja J; Słuszniak J; Serkies K; Kładny J; Pamucka M; Kukołowicz P
    Radiother Oncol; 2004 Jul; 72(1):15-24. PubMed ID: 15236870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer.
    Tural D; Ozturk M; Selcukbiricik F; Yildiz O; Elicin O; Turna H; Guney S; Ozguroglu M
    J BUON; 2013; 18(2):385-90. PubMed ID: 23818350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of ¹⁸F-FDG-PET for early detection of suboptimal response of rectal cancer to preoperative chemoradiotherapy: a prospective analysis.
    Leibold T; Akhurst TJ; Chessin DB; Yeung HW; Macapinlac H; Shia J; Minsky BD; Saltz LB; Riedel E; Mazumdar M; Paty PB; Weiser MR; Wong WD; Larson SM; Guillem JG
    Ann Surg Oncol; 2011 Oct; 18(10):2783-9. PubMed ID: 21476107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organ Preservation in the Treatment of Stage II and III Rectal Cancer.
    Hagen ER; Cleary RK
    Dis Colon Rectum; 2020 Sep; 63(9):1185-1189. PubMed ID: 33216489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simple criteria to predict margin involvement after chemoradiotherapy and sphincter-sparing for low rectal cancer.
    Dumont F; Tilly C; Dartigues P; Goéré D; Honoré C; Elias D
    Eur J Surg Oncol; 2015 Sep; 41(9):1210-6. PubMed ID: 26108736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications after sphincter-saving resection in rectal cancer patients according to whether chemoradiotherapy is performed before or after surgery.
    Kim CW; Kim JH; Yu CS; Shin US; Park JS; Jung KY; Kim TW; Yoon SN; Lim SB; Kim JC
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):156-63. PubMed ID: 20106604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.